Growth Equity Opportunities IV, LLC

Growth Equity Opportunities IV, LLC is a declared insider at 4 companies; the most frequent names are Aveo Pharmaceuticals, Inc., Cascadian Therapeutics, Inc. and Achaogen, Inc. Between 19 December 2016 and 21 December 2018, the trades on record add up to 30 filings.

Market trades split into 27 purchases (€17.1M) and 1 sale (€595k). On balance, insiders were net buyers of €16.5M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2018 alone, the filings show 25 purchases and 1 sale.

A typical purchase (the median) is worth €286k. On 27 out of 27 purchases, another insider of the same company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster.

Most recently, on 21 December 2018, the filings show an open-market purchase worth €286k in Aveo Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.